Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities

被引:12
|
作者
Li, Song [1 ,2 ]
Le, Weidong [1 ,2 ,3 ]
机构
[1] Dalian Med Univ, Clin Res Ctr Neurol Dis, Affiliated Hosp 1, Dalian 116011, Peoples R China
[2] Dalian Med Univ, Liaoning Prov Key Lab Res Pathogen Mech Neurol Di, Affiliated Hosp 1, Dalian 116011, Peoples R China
[3] Dalian Med Univ, Collaborat Innovat Ctr Brain Sci, Affiliated Hosp 1, Dalian 116011, Peoples R China
基金
中国国家自然科学基金;
关键词
DIAGNOSIS;
D O I
10.1007/s12264-017-0184-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:481 / 482
页数:2
相关论文
共 50 条
  • [31] The Past, Present, and Future of Telemedicine for Parkinson's Disease
    Achey, Meredith
    Aldred, Jason L.
    Aljehani, Noha
    Bloem, Bastiaan R.
    Biglan, Kevin M.
    Chan, Piu
    Cubo, Esther
    Dorsey, E. Ray
    Goetz, Christopher G.
    Guttman, Mark
    Hassan, Anhar
    Khandhar, Suketu M.
    Mari, Zoltan
    Spindler, Meredith
    Tanner, Caroline M.
    van den Haak, Pieter
    Walker, Richard
    Wilkinson, Jayne R.
    [J]. MOVEMENT DISORDERS, 2014, 29 (07) : 871 - 883
  • [32] Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    [J]. ACTA NEUROPATHOLOGICA, 2010, 120 (03) : 385 - 399
  • [33] Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease
    William T. Hu
    Alice Chen-Plotkin
    Steven E. Arnold
    Murray Grossman
    Christopher M. Clark
    Leslie M. Shaw
    Leo McCluskey
    Lauren Elman
    Jason Karlawish
    Howard I. Hurtig
    Andrew Siderowf
    Virginia M.-Y. Lee
    Holly Soares
    John Q. Trojanowski
    [J]. Acta Neuropathologica, 2010, 120 : 385 - 399
  • [34] Antioxidant Therapeutics in Parkinson's Disease: Current Challenges and Opportunities
    Duarte-Jurado, Ana Patricia
    Gopar-Cuevas, Yareth
    Saucedo-Cardenas, Odila
    Loera-Arias, Maria de Jesus
    Montes-de-Oca-Luna, Roberto
    Garcia-Garcia, Aracely
    Rodriguez-Rocha, Humberto
    [J]. ANTIOXIDANTS, 2021, 10 (03) : 1 - 19
  • [35] Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
    Prasuhn, Jannik
    Davis, Ryan L.
    Kumar, Kishore R.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [36] Porous Hydrogels: Present Challenges and Future Opportunities
    Foudazi, Reza
    Zowada, Ryan
    Manas-Zloczower, Ica
    Feke, Donald L.
    [J]. LANGMUIR, 2023, 39 (06) : 2092 - 2111
  • [37] Perception of the disease in patients with Parkinson's disease: past, present and future
    Jandeaw, Onnalin
    Jagota, Priya
    Singmaneesakulchai, Surat
    Boonrod, Nonglak
    Kaewwilai, Lalita
    Boonpang, Kamolwan
    Devahastin, Ratanaruedee
    Brenden, Neil
    Bhidayasiri, Roongroj
    [J]. MOVEMENT DISORDERS, 2014, 29 : S18 - S19
  • [38] Biomarker Discovery and Validation for Parkinson's Disease: A Machine Learning Approach
    Bazazeh, Dana
    Shubair, Raed M.
    Malik, Wasim Q.
    [J]. 2016 INTERNATIONAL CONFERENCE ON BIO-ENGINEERING FOR SMART TECHNOLOGIES (BIOSMART), 2016,
  • [39] Clinical milestones in Parkinson's disease: Past, present, and future
    Marsili, Luca
    Mahajan, Abhimanyu
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 432
  • [40] Parkinson's disease and primate research: past, present, and future
    Pereira, EAC
    Aziz, TZ
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (967) : 293 - 299